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Abstract
Gene expression is the fundamental level at which the results of various
genetic and regulatory programs are observable. The measurement of
transcriptome-wide gene expression has convincingly switched from mi-
croarrays to sequencing in a matter of years. RNA sequencing (RNA-seq)
provides a quantitative and open system for profiling transcriptional
outcomes on a large scale and therefore facilitates a large diversity of
applications, including basic science studies, but also agricultural or clinical
situations. In the past 10 years or so,much has been learned about the charac-
teristics of the RNA-seq data sets, as well as the performance of themyriad of
methods developed. In this review, we give an overview of the developments
in RNA-seq data analysis, including experimental design, with an explicit
focus on the quantification of gene expression and statistical approaches
139
Review in Advance first posted on 
April 30, 2019. (Changes may still 
occur before final publication.)
A
nn
u.
 R
ev
. B
io
m
ed
. D
at
a 
Sc
i. 
20
19
.2
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
 
A
cc
es
s p
ro
vi
de
d 
by
 U
ni
ve
rs
ity
 o
f G
en
t o
n 
07
/0
8/
19
. F
or
 p
er
so
na
l u
se
 o
nl
y.
 
BD02CH07_Robinson ARjats.cls April 20, 2019 13:18
for differential expression. We also highlight emerging data types, such as single-cell RNA-seq
and gene expression profiling using long-read technologies.
INTRODUCTION: OVERVIEW OF THE RNA SEQUENCING ASSAY
After that it gets a bit complicated, and there’s all sort of stuff going on in dimensions thirteen to
twenty-two that you really wouldn’t want to know about. All you really need to know for the moment
is that the universe is a lot more complicated than you might think, even if you start from a position of
thinking it’s pretty damn complicated in the first place.
—Mostly Harmless by Douglas Adams
Molecular biologists use gene expression studies to get a snapshot of the RNA molecules present
in a biological system, which dictates what cells are doing or are capable of. The original RNA
sequencing (RNA-seq) protocols, published over 10 years ago (1–5), described the sequencing of
complementary DNA (cDNA) fragments on a large scale from a population of cells. Since then,
the system has been optimized for different types and qualities of starting material, as well as
different research questions, and many mature protocols are available.
A basic overview of the main steps in a standard RNA-seq experiment is given in Figure 1.
The first step is the extraction and purification of RNA from a sample, followed by an enrichment
of target RNAs. Most commonly used is poly(A) capture, to select for polyadenylated RNAs, or
ribosomal depletion, to deplete ribosomal and transfer RNAs that are highly abundant in a cell
(approximately 95% of total RNA) (6) and are usually not of primary interest (7). The selected
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Figure 1
Overview of the experimental steps in an RNA sequencing (RNA-seq) protocol. The complementary DNA (cDNA) library is
generated from isolated RNA targets and then sequenced, and the reads are mapped against a reference genome or transcriptome.
Downstream data analysis depends on the goal of the experiment and can include, among other things, assessing differential expression,
variant calling, or genome annotation.
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RNAs are then chemically or enzymatically fragmented tomolecules of appropriate size (e.g., 300–
500 bp for Illumina’s TruSeq). Current dominant systems (e.g., Illumina) only sequence DNA;
single-stranded target RNAs are thus reverse-transcribed to cDNA (first strand), the RNA is then
degraded, and the first-strand cDNA is complemented to a double strand. Adapter sequences are
either ligated to the 3′ and 5′ end of the double-stranded cDNA or used as primers in the reverse
transcription reaction. The final cDNA library consists of cDNA inserts flanked by an adapter
sequence on each end. In the last step, the cDNA library is amplified by polymerase chain reaction
(PCR) using parts of the adapter sequences as primers.
For Illumina sequencing, the library is loaded onto a flow cell where the cDNAs bind to
short oligonucleotides complementary to the adapter sequence.Bridge amplification creates dense
clonal clusters of each cDNA loaded (8). The sequence of each cluster is determined by a pro-
cess called sequencing by synthesis (9): Single-stranded templates are read as the complementary
strand is generated. A single fluorescently labeled deoxynucleoside triphosphate (dNTP) is added
in each step.The label acts as a terminator and prevents the incorporation of more than one dNTP
at the same time. After the fluorescent label has been imaged, it is enzymatically cleaved and the
next dNTP can bind to the chain. Base calls are inferred directly from the measured fluorescent
signal intensity.
cDNA libraries can be sequenced in one of two modes: single-end or paired-end. In single-end
mode, only one end of the cDNA insert is sequenced, whereas in paired-end mode, both ends are
sequenced, yielding two reads in opposite orientation, one from each end.
There are protocols for unstranded and stranded RNA-seq (10, 11), where the latter preserves
information about the coding strand of each fragment,which is useful in compact genomes or with
expressed RNAs that originate from opposite strands of the same genomic locus. One possibility
to construct a stranded library is to use deoxyuridine triphosphates (dUTPs) in the generation
of the second strand cDNA and to degrade the dUTP-labeled cDNA before PCR amplification
(12). Other protocols use alternative adapters to distinguish between 5′ and 3′ ends of the RNA
(13).
RNA-seq has greatly evolved over time,with early experiments having 35-bp reads andmodern
(Illumina-based) experiments typically employing 50-bp (single-end) or 100-bp (paired-end) reads
(Figure 2a).Most RNA-seq experiments comprise between 10 and 100million reads, with a trend
toward deeper sequencing over time (Figure 2b).The number of samples per project has remained
constant over the years,with amedian of around eight samples (Figure 2c).Rapid enhancements in
sequencing technology have enabled not only longer read lengths (e.g., 250–300 bp for Illumina’s
MiSeq) and much higher throughput for the same cost, but also much lower amounts of required
starting material. Meanwhile, third-generation technologies, such as Pacific Biosciences (PacBio)
and Oxford Nanopore Technologies (ONT), allow the sequencing of single molecules and have
now been used for sequencing full-length transcripts on a transcriptome-wide scale (14). Further
developments are summarized below in the section titled Long-Read Transcriptome Sequencing.
In addition, single-cell RNA-seq (scRNA-seq) is a rapidly emerging technique that can be used to
sequence the sparse transcriptome of individual cells. Some of the early developments in this area
are captured in the section titled Single-Cell Transcriptome Sequencing.
Design Aspects of RNA-seq
The basics of scientific experimental design apply equally for RNA-seq experiments (e.g., see
Reference 16). For example, whether the desired experiment is a simple two-group design or a
full factorial design, one should consider randomizing experimental units to treatments to avoid
confounding factors (e.g., via blocking over batches). If the experiment is run in multiple batches
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Figure 2
Ridge plots showing the progression of read length, depth, and sample size in Sequence Read Archive (SRA) projects using the
recount package (15). The projects are separated by the submission year of the biosample. (a) Median read length of all samples per
project and year. (b) Median number of reads across all samples per project and year. (c) Number of samples in each project. Each point
represents one project.
(e.g., a limited number of samples per run), it is critical to represent every experimental condition
in each batch, so that, when comparing conditions, differences within a batch can be averaged over
in the statistical modeling.
Specific aspects to be considered while designing an RNA-seq experiment include the number
of replicates and the depth of sequencing. Ultimately, in modern genomic experiments where re-
sources (e.g.,material from subjects) are scarce and the RNA-seq experiment is itself a hypothesis-
generating tool, the first driver of sample size is budget.Many RNA-seq studies use as few as three
replicates per condition (Figure 2c), near the minimum required to do any statistical analysis.
Sample size calculators can compute the required number of samples to achieve a user-defined
power for detecting differential expression (DE) (17–20). However, the user must define many
parameters, such as the expected alignment rate, the desired power, the significance level, and the
log-fold change (LFC) of DE genes. A recent study concluded that the recommended sample sizes
vary across tools, even when estimates from pilot data are available (21). Another issue with sample
size calculators is how to precisely define the outcome: Do we want to find as many DE genes as
possible? Do we want a certain power for the lowly expressed genes or the highly expressed ones?
Inmany cases,RNA-seq experiments are exploratory and thus ameans to further experimentation.
Nonetheless, there is a trade-off between the number of samples and the sequencing depth in
terms of discovery performance. Increasing the number of reads might seem always beneficial, but
a large proportion of the reads originate from a small pool of highly expressed genes, and there
is effectively no signal saturation. Figure 3 highlights that more than 80% of reads are attributed
to the 10% most expressed genes, acknowledging that transcript length also plays a role (22).
An increased number of reads only marginally increases the coverage of lowly expressed genes,
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Figure 3
Cumulative proportion of reads among the top expressed genes. The x-axis orders genes according to the
total number of reads they attract, and the y-axis displays the cumulative fraction of total reads. Each line
represents a single sample. Counts were downloaded from recount (15), and 50 samples were randomly
selected from accession number SRP060416.
and therefore, the statistical power to detect DE does not improve considerably, especially if the
experiment already comprises∼10million reads per sample (23). Inmost cases, the budget is better
spent on replicates. For example, Schurch et al. (24) showed that a higher number of replicates
is required to identify DE genes with low-fold change, and that ideally at least six replicates per
condition should be used.
There are options for additional capture of genes with low expression, but these require addi-
tional labor and cost. In targeted RNA-seq (RNA CaptureSeq), specific regions are first captured
by probes that are complementary to the region of interest and these selected regions are prepared
and sequenced (25, 26). After capture, the quantitative nature of the assay is maintained (25); such
capture is especially useful in degraded samples (e.g., patient material stored in paraffin blocks)
where the poly(A) tails may not be present.
RNA-seq Applications
Clearly, the popularity of RNA-seq is driven by its large number of applications. One obvious
application area is genome annotation. Even the well-studied transcriptomes of humans or model
organisms such as mice, zebrafish, or fruit flies are not complete. Thus, transcriptomics is used to
annotate novel transcriptional events, such as exon skipping, alternative 3′ acceptor or 5′ donor
sites or intron retention and to understand their usage in normal, developmental, or pathological
conditions.Transcriptomic studies identified previously unknown phenomena, such asmicroexons
(27), cryptic exons (28), so-called skiptic exons (29), circular RNAs (30), enhancer RNAs (31),
fusion genes (32), and so-called epitranscriptomics involving RNA base modifications (33).
One of themain application areas is gene regulation.RNA-seq enables the comparison of gene/
transcript/exon expression between different tissues, cell types, genotypes, stimulation conditions,
time points, disease states, growth conditions, and so on. Ultimately, the goal of such comparisons
www.annualreviews.org • RNA Sequencing Data 143
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is to identify the genes that change in expression to understand the molecular pathways that are
used or altered or the regulatory components that are utilized.
Gene expression has been used for the molecular subclassification of cancer since the early days
ofmicroarrays (34).RNA-seq offers this same capacity but at higher resolution and can include, for
example, categorization by splicing (35). There is considerable interest in using RNA-seq in clini-
cal applications to augment or corroborate the information given by genome sequencing (36, 37).
Other applications include spatial transcriptomics, where cellular positional information is main-
tained in the preparation of cDNA fragments (38); host–pathogen interactions via dual RNA-seq,
where the transcriptomes of both host and pathogen are simultaneously assayed (39); the analysis
of genetic variation among expressed genes (40); RNA editing events (41); the characterization of
long noncoding RNAs (42); and metatranscriptomics (43).
Despite the many use cases for bulk RNA-seq, there are applications where single-cell resolu-
tion is desired, especially when studying heterogeneous tissues that consist of more than one cell
type. While bulk RNA-seq can be computationally deconvoluted to estimate the composition of
cells present (44), it is not possible to discover new cell types or perform cell-type-specific analyses
with bulk RNA-seq, and thus scRNA-seq opens the door to new applications.
Outline
This review focuses on data analysis aspects, the computational steps involved (focusing on DE),
various statistical and computational challenges, and the approaches that have been proposed to
address them.We focus on Illumina-based RNA-seq data on model organisms, as that is the dom-
inant application area. There are already excellent reviews for major application or computational
areas, such as de novo (or reference-based) transcriptome assembly (45), allele-specific expression
analyses (46), expression quantitative trait loci mapping (47), splicing (48), analysis of gene reg-
ulatory networks (49), and pathway analyses (50, 51). In most applications, the overarching goal
is to identify DE, either at the gene, transcript, or exon level. The set of DE entities provides a
snapshot into the molecular underpinnings of a stimulus, a disease condition, a genetic mutation,
or any other perturbation being interrogated. In most cases, DE is only an intermediate (although
critical) step to understanding the biological system under study.
The review is organized as follows. First, we discuss alignment and quantification,where RNA-
seq reads are placed in the context of the genome or annotation catalogs and the relative expression
level of each target is assessed. Following quantification, we discuss the basics of DE, to lay the
foundation for the current frameworks, and variants of DE, to highlight the diverse conceptual
tools available to run the discovery process. Finally, we discuss two rapidly evolving research areas
that have experienced considerable activity in recent years, single-cell transcriptome sequencing
and long-read transcriptome sequencing (LRTS).
ALIGNMENT AND QUANTIFICATION
After an experiment has been conducted, the analyst is presented with files containing up to bil-
lions of short cDNA fragments. Following sufficient quality control of the sequencing reactions,
alignment to a reference genome or (de novo assembled) transcriptome is one of the critical steps
in translating the raw data into something quantitative.
Because the sequenced fragments are derived from cDNA corresponding to fully (or partially)
spliced transcripts, reads often span the boundaries of splice junctions (SJs), resulting in so-called
junction-spanning reads (Figure 4). This results in contiguous read sequences whose constituent
subsequences may be separated by tens of thousands of nucleotides. This poses a considerable
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a   Spliced alignment against genome
b   Unspliced alignment against transcriptome
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Figure 4
An illustration of spliced alignment of RNA sequencing (RNA-seq) fragments to a genome (a) and direct
alignment to a transcriptome (b). Reads are designated by thick solid lines, while dashed arcs represent the
pairing relationship between paired-end reads. This illustration depicts alignment to a single four-exon gene
consisting of three distinct transcripts. In the spliced alignment (a), the left read of the rightmost pair is a
junction-spanning alignment to the red–green exon boundary. In the direct alignment to the transcriptome
(b), one observes how the same alignment (e.g., the alignment to the blue exon) is repeated for each
transcript.
computational challenge, as the position of SJs in spanning reads needs to be accurately identified
for a read to be properly aligned. There are two main approaches for handling spliced reads, each
with its own challenges and benefits: a spliced alignment against a reference genome or an un-
spliced alignment against a reference transcriptome (a database of all isoforms). A main challenge
in spliced alignment against a reference genome is the proper alignment of reads that span an
SJ, especially when these junctions are not annotated a priori. Meanwhile, the main challenge in
unspliced alignment to a transcriptome is the redundant sequence among related isoforms, which
often leads to a high multimapping rate.
Spliced Alignment to a Reference Genome
A popular solution for handling RNA-seq alignments is to use a splice-aware aligner. Early RNA-
seq aligners, e.g.,TopHat (52),made use ofDNA-seq aligners, such as Bowtie (53), by first building
a catalog of putative SJs to which the reads can be directly aligned.
More recent splice-aware alignment tools (54–64) account for read splicing directly. They also
can utilize the locations of known SJs and discover previously unannotated SJs. When a read
partially aligns, the annotated SJ database is consulted to check if the alignment ends prematurely
as the result of the read spanning a known splice site. In this case, compatible downstream splice
sites can be considered as candidate loci to align the remaining portion of the read. Even if no
annotated splice site exists at the point where the alignment ends, the tool can interrogate the
terminal nucleotides in the partial alignment to see if they are compatible with known canonical
(or user-provided) donor or acceptor sites, providing evidence that the partial alignment stops as
the result of a splicing event.
One of the primary difficulties in aligning reads across SJs is that only a small portion of the
read spans into one of the exons. Splice-aware aligners including STAR (55), HISAT(2) (56),
www.annualreviews.org • RNA Sequencing Data 145
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Subread (57), and GMAP (58) attempt to deal with such cases by using evidence from reads that
confidently align across SJs. In such strategies, new SJs are added to the index when they display
high-confidence evidence, i.e., when multiple reads with a sufficient anchoring sequence span the
SJ. Trusted SJs are then used to help align reads that start or end near junction boundaries.
Unspliced Alignment to a Reference Transcriptome
In organisms where transcriptomes are well characterized, an alternative to splice-aware genome
alignment is direct transcriptome alignment, which consists of aligning against a set of known
transcripts. Since the transcript sequences are already spliced, reads should align contiguously,
and many of the computationally expensive steps and heuristics can be avoided. Moreover, when
no reasonable quality reference genome is available for reference-based transcript assembly (e.g.,
when a transcriptome has been assembled de novo), alignment directly to the assembled tran-
scripts is the only available option. However, transcriptome alignment induces a high degree of
multimapping, and dealing with this becomes a primary computational challenge. For example,
if a gene has three distinct isoforms, a constitutive exon of this gene will appear three times in
the transcriptome reference (e.g.,Figure 4b). Additionally, mapping only to annotated transcripts
does not allow one to find novel splicing or expression patterns (e.g., novel exons), and it be-
comes difficult to assess retained introns or partial splicing; of course, it is possible to augment the
transcriptome with unspliced variants. The choice of genome versus transcriptome alignment is
largely driven by the desired target application and the constraints of downstream analyses.
Gene- and Transcript-Level Quantification From RNA-seq Data
One of the main uses of RNA-seq is to assess gene- and transcript-level abundances. Accurate
abundance estimation is crucial to common downstream applications, including assessing all the
notions of DE. Most commonly, abundances are estimated at the level of genes, but recently
transcript-level abundances have become more widely used, and there are trade-offs in choosing
between the two levels of resolution.
Gene-level quantification consists of assigning fragments (reads or read pairs) to genes, where
the gene is often taken to represent the amalgamation of all transcripts produced from a specific
strand at a specific locus (65), which typically share some exons or parts of exons. The total ex-
pression of a gene is the sum of the expression of its isoforms. Any fragment arising from any
isoform of a gene is assigned to the underlying gene. There are typically two paths that can be
taken to obtain gene-level quantifications: direct fragment overlap counting of gene features, and
transcript-level quantification followed by aggregation to the gene level.
Direct fragment counting of gene features is done by first mapping RNA-seq reads to the
genome with a splice-aware aligner, and then using a tool like featureCounts (66), HTSeq (67),
or the built-in capability of STAR (55) to assess how many fragments overlap each gene; the same
approach can be used to quantify other disjoint genomic features, such as nonoverlapping exonic
segments. Even in this basic pipeline, there are many ways certain conditions can be handled. For
example, should a fragment reside completely within a feature to be counted? If a fragment maps
to multiple features, should it be discarded, counted toward each feature, or somehow partially al-
located? Of course, direct fragment counting approaches exhibit desirable features: They are con-
ceptually simple and typically quite fast. Conversely, they suffer from various disadvantages: They
have no principled way of handling multimapping reads (e.g., arising from paralogous genes), and
they are oblivious to potentially important compositional changes not reflected directly in gene-
level read counts (e.g., isoform switching). Additionally, since such methods assess the frequency
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of reads overlapping a gene, they must grapple with the definition of a gene. For example, should
a gene be the union or the intersection of exons of all transcripts of the gene? Should intronic
reads be included? Although the concept of a gene is a useful abstraction, transcripts are assayed
in RNA-seq and so present a conceptually cleaner target for quantification.
Transcript-level quantification consists of the assignment of fragments to specific transcripts,
which is more challenging but has a number of advantages. It admits a clear interpretation, since
transcripts are what the cell expresses; it allows for improved biological resolution and decoding
of potentially important biological changes, such as isoform switching; it is the most appropriate
level to model and correct for technical biases (68–71); and it provides a proper model for han-
dling reads that multimap, as failing to do so can lead to systematically poor quantification for
genes in gene families (72). Solving the transcript-level abundance estimation problem requires
a principled solution to aggregating to gene-level estimates (73–75). Conversely, transcript-level
quantification is not without disadvantages. Alternative splicing implies that many fragments are
ambiguous in their origin, and they must be assigned probabilistically, necessitating the adoption
of amodel,whichmay fail to adequately capture reality; this read ambiguity translates to additional
uncertainty in the estimated transcript abundances.
Transcript Quantification
Methods for transcript quantification are based primarily on defining a generative model of RNA-
seq reads and then trying to perform inference on this model to obtain the relevant quantities
(i.e., transcript abundances); see Figure 5. There has been a tremendous amount of research on
quantifying transcript-level abundance from high-throughput sequencing data; here we describe
a few major highlights.
Initial probabilistic frameworks for transcript identification and abundance estimation using
EST (expressed sequence tags) data were already being developed before Illumina-based sequenc-
ing (76), but Jiang &Wong (77) were among the first to attempt isoform-level abundance estima-
tion using RNA-seq data. They defined counts over exons and exon junctions as arising according
to a Poisson model and viewed transcripts as vectors of inclusion and exclusion of these exons
and junctions. By expressing the likelihood of the model parameters given the observed data, they
posed a statistical model that admits efficient inference, for which they obtained the point esti-
mate by gradient ascent and provided estimates of the posterior distributions of the parameters
via importance sampling. This work represents one of the first proper statistical formulations of
the problem. However, the approach does not account for fragments that map to multiple genes,
and it requires annotations of transcripts in terms of the gene–transcript relationship, as well as
the exon and junction read inclusion matrix.
Li et al. (73, 78) proposed one of the most widely adopted generative models for transcript
quantification, RSEM. They defined a fragment-level model of RNA-seq experiments in terms
of sampling molecules from an underlying population, proportional to the product of their abun-
dance and length, and then generated fragments from the sampled molecules. Primary quantities
of interest are estimated, including the nucleotide fractions (the fraction of all sequenced nu-
cleotides deriving from each transcript) and the transcript fractions (the fraction of all transcripts
in the initial population comprising each transcript species); these quantities can be directly con-
verted into popular abundance units, such as transcripts per million (TPM) or estimated counts.
Notably, they proposed computing the maximum likelihood (ML) estimates using an expectation-
maximization (EM) algorithm (see Figure 5) and introduced a modified Gibbs sampling proce-
dure to allow estimating credible intervals for the abundance estimates (73). The model is quite
general: It works at the fragment level, and it can account for numerous protocol-related aspects,
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Figure 5
An illustration of the alignment of various reads to a gene with three isoforms: blue (B), green (G), and red (R). In this example, we wish
to estimate the abundances of these isoforms, but most reads have ambiguous origins and need to be probabilistically assigned to the
transcripts (relative probabilities for each read are shown by the magnitudes of the three colors). Some reads are consistent only with
the B and G transcripts, and a few reads uniquely align to a single transcript (single color). In the expectation-maximization (or related)
algorithm, given the current abundance estimates, fragments are probabilistically assigned to transcripts, and then estimated
abundances are updated by summarizing the (proportional) allocations over all fragments; transcript abundance estimates are
determined by iterating the procedure until convergence.
including single-end and paired-end sequencing, directional versus unstranded protocols, vari-
ous coverage biases, etc. Further, the model relies only on the transcript sequences and not on
the relationships to genes or annotations of exons and SJs. Thus, it can be easily applied to both
well-characterized and newly assembled transcriptomes.One drawback of a fragment-level model,
however, is that eachEM iteration scales with the total number of alignments,which is indeed large
in most RNA-seq experiments.
Instead of modeling each fragment individually, MMSeq models sufficient statistics (79, 80).
Reads are categorized into equivalence classes, where two reads are equivalent if they align to the
same set of transcripts. The approach works both within and across genes and does not require
the shared regions that give rise to the equivalence classes to correspond to any known annotation
(e.g., exon or SJ). MMSeq uses an EM method that works directly over these equivalence classes,
allowing efficient inference of transcript-level abundance in this model. In addition to this ML
approach, a Gibbs sampling procedure was introduced that can estimate transcript abundances
using summary statistics from samples of the estimated posterior, which also allows one to assess
uncertainty in the transcript-level abundance estimation and groups of transcripts with correlated
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posterior estimates. The underlying likelihood function of the equivalence class–based model is
not equivalent to that of the fragment-level model in RSEM, although subsequent work explored
other factorizations of the full fragment-level likelihood that either preserved equality with the
RSEM model while speeding up inference (81) or sacrificed equality to balance efficiency and
fidelity (82, 83). eXpress demonstrated how fragment-level inference could be made much more
efficient by modifying the inferential algorithm itself (i.e., online EM), rather than the factoriza-
tion of the underlying likelihood function (84, 85).
Cufflinks is widely known as both a reference-guided transcript assembly algorithm and a quan-
tification tool (86).Quantification either is restricted to a reference annotation or allows new tran-
scripts to be identified via alignments; transcript abundances are estimated via an EM algorithm to
determine theML estimates given the observed data.While we do not focus on assembly methods
here, given the close relationship between transcript identification (assembly) and quantification,
numerous approaches attempt to solve both problems together, either stagewise or jointly (82,
87–94).
BitSeq introduced a model similar to RSEM that jointly performs quantification and DE, to-
gether with fully Bayesian inference (95). BitSeq focused on sampling from the posterior distri-
butions of transcript abundances, given the fragment alignments, giving accurate estimates (96)
and useful information about posterior uncertainty and posterior correlation, which is used in the
DE step (95). To combat the heavy computational requirements, Hensman et al. (97) introduced
a variational Bayesian (VB) approximation that can be efficiently optimized. TIGAR introduced
a VB approach to the transcript abundance estimation problem (98), and the VB EM algorithm
was shown to outperform the standard EM algorithm. However, Hensman et al. (97) introduced
a novel optimization procedure called VBNG (VB natural gradient), which is a gradient ascent al-
gorithm that considers the information geometry (99) of the underlying problem. Hensman et al.
also suggested that EM-based methods tend to find solutions near the boundary of the parame-
ter space, and that their quantifications are less robust than either fully Bayesian or VB estimates
(97).
Many of these approaches, among others, simplify the model or improve the efficiency of the
inferential procedure, but all rely on full alignments of each read,which can be computationally in-
tensive and time consuming. Recently, several new methods bypass the alignment step and instead
adopt lightweight models for quantification. Sailfish defines the transcript abundance likelihood in
terms of the constituent k-mers of the underlying transcriptome and their abundance in the read
data (100). Since the k-mers are completely known in advance, the relevant equivalence classes
can be precomputed, which reduces the inferential problem to one of simply counting k-mers
and performing inference via an EM algorithm such as the SQUAREM algorithm (101). This ap-
proach increases the speed of abundance estimation by over an order of magnitude compared to
full alignment approaches. Building on the idea of k-mer-based abundance estimation,RNA-Skim
takes the approach of Sailfish even further, identifying sets of distinctive k-mers, termed sigmers
(102). Transcripts are clustered into groups, and sigmers are identified as k-mers that are unique
to (and indicative of ) each cluster. Quantification is then performed by counting the sigmers in
the read data, instead of all k-mers, and the EM algorithm is used to estimate transcript abun-
dances from sigmer equivalence class counts. While very fast, these k-mer based approaches do
not retain the coherence of the k-mers along a read, which can reduce specificity, and they cannot
easily estimate certain aspects of the generative model, like the fragment length distribution. Ad-
dressing these shortcomings, kallisto relies on the use of pseudoalignments to directly compute
the sufficient statistics of the equivalence class–based model of transcript abundance estimation
(103). This approach uses k-mers to identify the transcripts with which fragments are compatible,
but does not treat the k-mers independently. The pseudoalignments can be computed in such a
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way that equivalence class counts are generated without considering or computing individual frag-
ment to transcript alignments, and this can often be achieved by querying only a small number of
the k-mers present in a fragment, allowing for efficient and accurate estimation in the equivalence
class–based model using an EM algorithm. Salmon is another lightweight quantification approach
that avoids full alignments, although they can still be used as input (104). It uses a two-phase al-
gorithm for transcript abundance estimation: an online phase using a stochastic collapsed VB in-
ference algorithm (105), where abundances and auxiliary parameters are estimated (e.g., GC bias
parameters, sequence-specific bias parameters, fragment length distribution) and an update using
mini batches of mappings. Salmon uses a lightweight mapping algorithm to compute the likely
transcripts, positions, and orientations of origin of each fragment and adopts a fragment-level GC
bias modeling approach (71), which reduces misidentification of expressed isoforms when read
coverage is not uniform along the transcripts due to GC content. In the offline phase, a factorized
likelihood function is optimized until parameter convergence. The granularity of the likelihood
factorization used by Salmon can be adjusted (83) in a way that allows one to trade off between
the fragment model of RSEM and the count-based model of MMSeq. In the offline phase, the
factorized likelihood is optimized using a VB EM algorithm (98) or a traditional EM algorithm.
Combining the efficient determination of fragment–transcript compatibility with RNA-Skim’s
sigmer concept, Fleximer uses a new matching algorithm that uses sets of sigmers to determine
the likely loci of origin of reads, instead of treating each sigmer independently (106). A generalized
suffix tree is used to organize the reference sequences, and a segment graph that demonstrates how
segments of sequence are shared among reference transcripts is used to select an informative and
robust set of sigmers for quantification. Reads are mapped against the reference by matching them
to sigmers using a precomputed automaton. This process produces a set of transcript equivalence
classes, along with a corresponding count for each sometimes termed the transcript compatibility
count; this is used with an EM algorithm to estimate transcript abundances.
Due to their vastly improved speed, ease of use, and reduced computational requirements,
alignment-free approaches have become popular for assessing transcript- and gene-level abun-
dance using RNA-seq data. Recent benchmarks (107–110) suggest that, in addition to being fast,
such methods can produce accurate abundance estimates—at least to the extent that simulation-
based studies, which sometimes adopt the assumed generative models of the quantification ap-
proaches, can be relied upon to assess such accuracy. However, there remain opportunities for
improving transcript-level quantification methods. For example, the underlying models can likely
be further enhanced to account for complexities in the fragmentation patterns of molecules prior
to sequencing (111), to better balance robustness and sample-specific accuracy (112), and to ad-
dress uncharacterized biases. Additionally, most of these approaches (lightweight and otherwise)
assume that the annotation of transcripts to be quantified is complete. The accuracy of quantifica-
tion can suffer when this is not the case, although it is possible to computationally flag transcripts
whose estimates are unreliable (113).
BASICS OF DIFFERENTIAL EXPRESSION
Following alignment and quantification, the next challenge often is assessing DE from the esti-
mated feature abundances. We first present a general context and describe the statistical frame-
works and overall workflow. The starting point is a count table with rows representing features
(e.g., genes) and columns representing samples (i.e., experimental units). The goal of DE is to for-
mulate and test a statistical hypothesis for each feature. Depending on the experimental design,
the context, and the research question,more complex analyses are often required.We elaborate on
further variations of the overall workflow in the section titled Variants of Differential Expression.
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Figure 6
Schematic overview of a DE analysis for RNA sequencing data. Red boxes correspond to pipelines for
count-based models (e.g., edgeR, DESeq2), while blue boxes correspond to a linear-model-based pipeline
(e.g., limma-voom).
The general workflow involves the following steps (see Figure 6): filtering and normalization
(preprocessing), specification of the statistical model and estimation of model parameters, statis-
tical inference on the relevant parameters, and adjustment for multiple testing.We introduce this
general workflow from the perspective of classical models for count regression. We then discuss
various notable deviations, including alternative estimation and inference frameworks and addi-
tional strategies to ensure robustness.
Typically, only a limited number of replicates are available (e.g., three to five replicates per
condition). The achievable statistical power from such small sample sizes can be low, even for a
single feature, with the real interest lying in inference on thousands of features simultaneously.
This parallel inference challenge is common to various genome-scale experiments, and the sta-
tistical community has contributed strategies to improve the overall performance, from which a
few themes have emerged. For example, in estimating parameters for a given feature, one should
consider the information coming from the other features in the data set (114). In general, ge-
nomics data are ripe for using empirical Bayes methods to moderate estimates, where priors for
a feature are derived from a suitable set of other features measured in the data set. In addition,
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moderating variance parameters is critical, and indeed, much of the success of earlier parallel in-
ference frameworks (e.g., for microarrays) can be attributed to variance moderation, whether in an
ad hoc strategy (115) or in hierarchical models (116).Other tricks such as regularization of regres-
sion parameters or considerations for robustness provide additional performance benefits. Taken
together, the challenges associated with vast parallel inference can be greatly eased by adopting
one or more of these strategies.
Preprocessing: Filtering and Normalization
The vast number of features in a typical RNA-seq experiment leads to a large multiple testing bur-
den. However, many features are largely uninformative; for example, features with low expression
provide little evidence for DE.Therefore, filtering strategies are employed that predominantly re-
move uninformative features and reduce the multiple testing burden. Bourgon et al. (117) showed
that filtering is valid if it is independent of the DE test statistic; thus, filtering on residual variance
is invalid, while filtering on expression strength, as is commonly done, is valid.
The observed counts of the features cannot be directly compared across samples since there
are differences in sequencing depth across libraries. Several methods have been developed to nor-
malize counts to facilitate cross-sample comparisons, although in most count-based models, the
counts themselves are not modified and instead scaling factors accompany the analysis. Initial at-
tempts focused on a simple correction for sequencing depth, using the total sum of counts for each
sample (i.e., the library size) as a scaling factor (3, 118). However, variation in library preparation
or RNA composition between samples also contributes to cross-sample variability and should be
accounted for (119). In addition, a few highly expressed genes can largely drive the sampling of
fragments, thus leading to inaccurate scaling of the counts. A popular approach is to calculate a
size factor (119, 120) for each sample. This can be considered a robust global fold change between
the current sample and a (pseudo) reference sample derived from all samples. DESeq’s median
of ratios method and edgeR’s trimmed mean of M-values (TMM) method (where M-values de-
note empirical fold changes between two samples) are the most popular scaling approaches (121).
Both procedures assume that most genes are not DE and adopt robust summarization methods
to calculate the size factors (effective library sizes) to reduce the impact of DE genes (TMM uses
a trimmed weighted mean; DESeq uses the median of the log-expression ratios). More advanced
normalization methods have since emerged to address other technical artifacts such as GC con-
tent and transcript length effects and to accommodate within- and between-lane normalization,
e.g., CQN (122) and EDASEQ (123).Moreover,methods based on external spike-in features have
been introduced to address normalization for applications where many features are DE or where
the basic assumptions of conventional normalization methods are violated (124–126). Recently,
a normalization technique has been proposed for RNA-seq data with large differences between
conditions that assumes similar distributions in biological replicates, while accommodating for
differences between conditions (127).
The normalization size factors are built into theDE analysis workflow as offsets in the statistical
models (see below).Notably, size factors are treated as fixed and known, although they are actually
random variables estimated from the data (128), and it is unclear how ignoring their associated
uncertainty affects the downstream DE analysis.
Modeling and Estimation
Because of the typically small sample size, DE tools mainly implement parametric methods (120,
129–132). Initially, count data were log-transformed and linear models were used for DE analysis
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(4). However, log-transformed counts suffer from heteroscedasticity (a systematic mean-variance
trend) intrinsic to count data, rendering the standard linear model, which assumes homoscedas-
ticity, suboptimal. In addition, fitting continuous models to (transformed) count data introduces
a further approximation. Therefore, discrete count distributions have gained more traction in the
initial frameworks.
Gene expression variability across technical replicates (i.e., resequencing the same sample),
so-called shot noise, has been shown to approximately follow a Poisson distribution (118), for
which the variance is equal to the mean. Biological replication introduces additional cross-sample
variability, and analysis frameworks therefore have resorted to one of the natural extensions, the
gamma-Poisson or the negative binomial (NB) distribution, which has an additional dispersion
parameter and a quadratic mean-variance relationship,
Yf i ∼NB(μ f i, ϕ f ),
Var(Yf i )=μ f i + ϕ f μ2f i,
where Yf i denotes the read count of feature f in sample i, ϕ f is the dispersion for feature f, and
μ f i = siθ f i represents the average expression, which is driven by the true (relative) mRNA con-
centration in the sample, θ f i, multiplied by a normalization scaling factor, si; there also exists a
characteristic dispersion-mean trend in RNA-seq data sets (Figure 7a). Initial implementations
focused on two-group comparisons (120, 133) and were later extended to the generalized lin-
ear model (GLM) framework, an extension of classical linear models to non-Gaussian responses
(134). GLMs allow for the inclusion of multiple treatments or covariates, thus broadening the
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(a) A dispersion-mean plot of the RNA sequencing (RNA-seq) experiment from Reference 135, as processed in Reference 136. The
dispersion trend smoothly decreases for genes with higher expression and eventually reaches an asymptote, which can be considered
the biological variability present in the data set for a typical gene. (b) MA (log ratio over mean) plot of the same RNA-seq experiment.
The y-axis shows the moderated log-fold change and the x-axis shows the mean of normalized counts. Red points denote differential
expression detection according to a nominal false discovery rate threshold of 0.05.
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applicability. The NB GLM model can be formulated as
Yf i ∼ NB(μ f i, ϕ f ),
log μ f i = η f i,
η f i = Xiβ f + log si,
where η f i is the linear predictor,Xi denotes the design matrix,β f represents the regression param-
eters, and log si are scaling (normalization) offsets. Regardless of the model, the parameters θ f i or,
equivalently, (a linear contrast of ) β f would represent the parameter(s) of interest for inference.
Reliable estimation of the dispersion parameter ϕ f is nontrivial due to limited sample sizes.
Traditional ML estimators for the dispersion are negatively biased (137) since they do not account
for the fact that the mean is also estimated from the data. Early implementations estimated a
single common dispersion parameter for all features (137), with the rationale to obtain a stable
estimate by borrowing strength over all genes. However, the common dispersion assumption is
unrealistic and relaxed estimation schemes were proposed, such as moderation toward a common
dispersion (133) or estimation in strata of similar expression strength (120). For example, DESeq
adopts a method of moments (MM) estimator and assumes the dispersion to be a smooth function
of the mean. To avoid too liberal inference, one then sets the dispersion as the maximum between
the smooth fit and the gene-wise MM estimate; however, while robust to outliers, this method
tends to overestimate the variance and is therefore conservative (138, 139). Later approaches
resorted to an approximate conditional inference scheme, the Cox–Reid adjusted profile like-
lihood (APL) (140), to correct for the bias in the ML estimator (134). Again, stable estimation
is provided by leveraging information across genes (Figure 8). In particular, edgeR uses a
maximized weighted APL to trade off between gene-specific and shared dispersion estimators
upon estimating the dispersion-mean trend across all genes (similar to DESeq). The weighted
likelihood,
APL f (ϕ f ) +G0APLs f (ϕ f ),
consists of the APL for a specific feature f (first component) and a shared likelihood (second
component), which can be interpreted as a prior from a Bayesian perspective, thus representing
an approximate empirical Bayes solution (133). The weight given to the prior likelihood,G0, can
also be estimated from the data (141). Analogously, DSS (Dispersion Shrinkage for Sequencing)
and DESeq2 model the log ϕ f as a Gaussian random variable, and Bayes’ formula is applied to
generate a posterior mode for each gene (129, 142). Hyperparameters for the (Gaussian) prior
are inferred from the data using either the MM or the Cox–Reid estimator across all genes. Once
dispersion estimates are available, the parameters of the mean model, β f , can be estimated using
standard algorithms for GLMs.
Statistical Inference
After fitting a GLM to each feature, the statistical inference typically involves testing the null
hypothesis H0 that there is no DE between conditions, i.e., that the LFC is zero, against the al-
ternative H1 that the LFC differs from zero. In the GLM framework, the null hypothesis can be
represented either as a single regression parameter or a linear combination of parameters (con-
trasts), which is defined by a vector or matrix L such thatH0 is the hypothesis that Lβ f = 0. Indeed,
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Figure 8
Steps in an empirical Bayes model. In an RNA sequencing experiment, one assesses the observed differences
in gene expression across groups of samples with respect to within-group variance. (a) The unobserved
population distribution for the true within-group variance of each gene. (b) Variances are estimated from
limited sample size experiments, and so there is sampling variance in our estimate of the variance. A
maximum likelihood estimate (MLE) or a bias-corrected estimator for expression variance can be used.
(c) Thousands of genes are typically observed and estimates are made for each, providing an empirical
distribution of MLEs across all genes. This empirical distribution of MLEs can be used to determine a prior
distribution for empirical Bayes analysis; the posterior distribution for the variance of each gene is calculated
using Bayes formula. (d) Distribution of the maximum a posteriori (MAP), or posterior mode, estimates of
variance over all genes. The posterior modes represent shrunken estimates, where the amount of shrinkage is
determined by the shape of the likelihood and the width of the prior distribution.
a regression parameter in anNBGLMwith a canonical link function can be interpreted as an LFC
between groups and thus provides a measure of effect size.
There are multiple hypothesis tests available for GLMs with known (asymptotic) distribution
under the null hypothesis. Likelihood ratio tests (LRTs) compare the likelihood of a full model,
upon estimating all parameters without constraints, with the likelihood of a reduced model, where
one or some of the parameters are constrained according to H0. LRT statistics are asymptotically
χ2-distributed under H0, and this type of test is implemented in both edgeR and DESeq2. By
default, however,DESeq2 adopts aWald test.Wald tests are attractive from a computational point
of view since they only require fitting the full model and calculating the variance–covariancematrix
of the regression coefficients. The Wald test statistic for a single model parameter or a single
contrast, W = ̂LFC /se(LFC), asymptotically follows a standard normal distribution under H0,
where se(LFC) is the standard error of LFC and ̂LFC is theML estimate of LFC. FromML theory,
it is known that LRTs have better properties (e.g., invariance to transformation) than Wald tests
in GLMs (143); however, RNA-seq tools moderate dispersion estimates and do not re-estimate
them under H0, so it is unclear whether these benefits carry over to RNA-seq data analysis in
practice.
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Multiple Testing
The p-values obtained from the statistical inferencemust be corrected for multiple testing to avoid
excess false positives. While it is possible to control the probability of returning at least one false
positive in the list of detections by adopting familywise error rate corrections, this stringent form
of correction is overly conservative. Indeed, when screening many thousands of features, one is
typically willing to tolerate a certain proportion of false positives to obtain a larger number of
true positives. The false discovery rate (FDR), which gained significant popularity, controls the
expected fraction of false positives in the detected set of features, i.e., FDR = E[V/max(R, 1)],
where V is the number of false positive rejections and R is the total number of detections. The
FDR was introduced by Benjamini & Hochberg (144) and has become common practice in high-
dimensional data analyses because of its simplicity and solid theoretical justification. Indeed, it can
be shown that the FDR is justified under a range of dependency structures between genes (145)
and can be approached from both frequentist and Bayesian perspectives.
Variations to the General Workflow
There is a large and growing number of alternatives to the basic framework mentioned above:
different inferences based on the same models, alternative models, more robust approaches, dif-
ferent testing regimes, variations on multiple testing corrections, and so on. In this section, we
summarize some of these developments.
Alternativemodels (inference frameworks).NB countmodels,which underpinmanyDE tools,
assume a quadratic mean-variance relationship. Inference, however, may benefit from a more flex-
ible variance structure, and for this, other models have been proposed. One strategy uses quasi-
likelihood (QL), which requires only that mean and variance are specified to able to make in-
ference on the mean model parameters (146). The QL method adopts the same mean model
structure as the NB but introduces an additional overdispersion parameter such that Var(Yfi) =
ψ f (μ f i + ϕ f μ2f i ), where ψ f is estimated using a moderated MM estimator. QL naturally allows
(asymptotic) hypothesis tests based on t- and F-statistics, thus accommodating the uncertainty
in the estimation of the additional QL dispersion parameter. Another variation is the use of a
more flexible distribution, such as the NB power distribution, which adds an additional parameter
(147) to the NB. Within the NB framework itself, Bayesian methods have also been developed.
A fully Bayesian approach has the benefit that various aspects of the posterior can be reported
(e.g., credible intervals), and the degree of parameter shrinkage naturally depends on the amount
of information available for that gene (a trade-off between expression magnitude, dispersion, and
residual degrees of freedom). One of the early methods was ShrinkBayes, a fully Bayesian ap-
proach that included multiple mixture priors (e.g., Gaussian) (148, 149) and where fitting was
accomplished using integrated nested Laplace approximations (150), which avoids the Markov
chain Monte Carlo sampling. Another alternative is to remain within computationally and in-
ferentially efficient Gaussian linear models, after suitably transforming the (normalized) count
data. For example, limma-voom models log-transform normalized counts using a linear model
while adjusting for heteroskedasticity via weighted regression, where the observation weights are
computed from the observed mean-variance relationship (151). In this case, moderated t- and
F-statistics are used for inference. Finally, nonparametric methods have been developed, which
are more robust to outliers and do not require distributional assumptions. For example, SAMSeq
(152) adopts the Wilcoxon test to assess DE between groups and uses resampling procedures to
adjust for differences in sequencing depth.
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Robust log-fold change estimation.The standard NB workflow typically makes use of APL
NB likelihood for parameter estimation, combined with empirical Bayes procedures to borrow
strength across features when estimating the dispersion parameter. There are two related chal-
lenges: (a) Ratios of smaller counts result in more variable LFCs (Figure 7b), and (b) the estima-
tion of LFC can be sensitive to outliers. This makes it difficult to rank genes according to LFC
since lowly expressed or outlier-affected genes are likely to dominate the top list. To derive more
robust LFC estimates, researchers have adopted several approaches. First, prior counts have been
used in the numerator and denominator of the LFC; effective shrinkage is accomplished by aug-
menting each count with a carefully chosen value, although the optimal value may vary across
data sets. Second, edgeR-robust (139), for instance, adopts an M-estimation approach by itera-
tively downweighting outlying observations within the GLM fitting procedure, dampening the
effect of outliers on both mean and variance estimates. Alternatively, outliers can be identified and
removed and/or imputed by taking advantage of the remaining data for a feature (129). Lastly,
priors can be imposed on the LFC parameters. For example, DESeq2 includes a zero-centered
Gaussian prior in the NB GLM and provides the posterior mode of LFC as output (129). The
width of the prior is set conservatively, using a weighted upper quantile of the observed LFCs.
New alternative shrinkage estimators in DESeq2 incorporate priors with heavier tails that intro-
duce less bias, using either a mixture of normal distributions (153) or a Cauchy distribution (154).
Accounting for unobserved effects. As mentioned above, (G)LMs can adjust for known con-
founders. However, genomic data can also be affected by unknown, and hence unobserved, con-
founders. This problem is widespread in publicly available data, which typically do not contain
sufficient metadata on potential batch effects caused by lab, protocol, date, etc. Batch correction
methods can leverage the parallel structure of high-throughput transcriptomic data to identify un-
known and unobserved systematic effects. SVA (surrogate variable analysis) (155, 156) and RUV
(remove unwanted variation) (125) methods, for instance, estimate surrogate variables through
singular value decomposition on control features or on a matrix of model residuals so that the
phenotypic effect of interest is not captured by the surrogates. RUV also has the option to exploit
information in replicate samples. The estimated surrogate variables can subsequently be included
as predictors in the statistical model to adjust for the batch effects.
Statistical inference by testing against a threshold.The standard approach for detecting DE
in RNA-seq involves a simple null hypothesis H0 that the LFC is zero. However, statistical sig-
nificance does not guarantee that the fold changes are large enough to be biologically relevant.
Analysts often produce candidate gene lists by applying a threshold on the magnitude of the LFC,
but the statistical properties of this approach are unclear. The FDR is a set property and has no
interpretation when the set, post-FDR calculation is altered (157). To address these practical and
theoretical concerns, researchers have adopted several tests relative to an LFC threshold, a pro-
cedure initially proposed for microarray data (158). This results in a composite null hypothesis
H0, such as |LFC| < a. Implementations differ: DESeq2 replaces the composite null with a sim-
ple null hypothesis at the boundary of the parameter space (129), whereas edgeR uses a modified
likelihood ratio test or a quasi-likelihood F-test against a threshold (159).
Small-sample inference.The null distributions for Wald or LRT statistics for count models are
only valid asymptotically, and the number of replicates is often too low for these approximations
to be fully effective, which may lead to an inflated FDR. Initial implementations provided exact
tests (137), but these can only be applied in simple designs. Another strategy is small-sample
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asymptotics, which makes use of higher-order approximations that are still compatible with the
GLM framework (160).
Multiple testing.While the FDR achieves amore reasonable sensitivity–specificity trade-off than
familywise error rate correction approaches, other developments beyond simple filtering aim to
further reduce the multiple testing burden. Storey’s q-value, for instance, estimates the propor-
tion of true null hypotheses from the data to increase power (161), while others adopt a data-
driven weighting of the p-values in the FDR correction (162). Although the FDR is deeply rooted
in statistical theory, it is not guaranteed that methods will control error rates at the nominal level
in real applications. NB methods, for instance, rely on the asymptotic theory, which might not
hold for applications with low sample sizes. A study has suggested that coregulation of genes in-
duces intergene correlations, which can alter the null distribution of the statistical test (163); local
FDR approaches were introduced that empirically estimate the null distribution (164). Other de-
velopments address issues in testing many hypotheses for every gene (e.g., multifactorial designs).
The conventional approach is to control the FDR on each hypothesis, but this does not allow for
straightforward prioritization since genes typically have a different ranking for each hypothesis.
Stagewise testing procedures can be interpreted as generalizations of analyses of variance with
post hoc tests for high-throughput contexts (165, 166), thus allowing a natural ordering of the
genes according to an omnibus test (all effects of interest) while providing FDR control at the
gene level.
VARIANTS OF DIFFERENTIAL EXPRESSION
The previous section introduced count-based DE in general terms: Each row of a count matrix is
submitted to a statistical model (often by first estimating moderated variance parameters over the
whole data set) and hypothesis tests of interest are conducted,with an adjustment for multiple test-
ing. In this section, we discuss additional approaches to interrogate RNA-seq data in terms of DE.
Although DE is of obvious interest, this can manifest or be defined in multiple ways (see
Figure 9). One may want to cast inferences to the gene level, but measurements are made at
the fragment level. We use the term “differential gene expression” (DGE) to refer to hypothesis
testing related to the total outcome of an annotated gene, by comparing either accumulated TPM
estimates or raw counts while including an adjustment for average transcript length via offsets
(74). If the expression of transcripts is the feature of interest (independent of other transcripts),
differential transcript expression (DTE) analyses can be conducted. Alternatively, one could be
interested in whether at least one transcript from a gene is DE. This requires statistical testing
at the transcript level and then aggregation to the gene level. Yet another strategy is to consider
whether the relative abundance (i.e., proportions) of transcripts for a specific genomic locus
changes between conditions, which is commonly termed differential transcript usage (DTU)
or, more generally, differential splicing (DS). A surrogate for DTU, differential exon usage, is
conducted on exon-level quantifications; in this case, the goal is to identify exons that deviate
from proportional expression to separate differential usage from DE. Yet another alternative is
to quantify and test differences at the event level, where reads supporting (or not supporting) an
event (e.g., inclusion of a cassette exon) are summarized and compared (167).
There is certainly a question of which analysis path to choose. Conceptually, pure DTE points
to all kinds of DE, and while casting a wide net of potentially interesting genes might seem appeal-
ing, there are some considerations to be made. For example, if a given transcript is DE, often the
question becomes, What happens to the expression of the other transcripts for this gene? Are all
transcripts changing in the same direction? If so, it may be better in terms of sensitivity to detect
158 Van den Berge et al.
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Figure 9
Schematic illustration of some examples of differential gene expression, differential transcript expression,
and differential transcript usage for a gene with three isoforms (1, 2, and 3) in a two-group comparison
(A versus B).
an aggregated output (i.e., DGE). Or, transcript-level expression can be represented as a genewise
multivariate outcome and isoform switches can be considered collectively, i.e., by assessing DTU,
which is not affected in either direction by DGE. DTU implies DTE while the opposite is not
necessarily true. We generally favor two clear but orthogonal analyses (DGE and DTU) over a
catchall DTE analysis (74), but this will ultimately be application dependent, and scientists should
clearly define their question of interest in advance.
Differential Transcript Expression
Modeling transcript-level count data for DE presents some additional challenges due to in-
creased variability and resolution compared to gene-level analyses. For example, transcript-level
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abundance estimates are considerably more variable than gene-level counts due to ambiguous as-
signment of fragments to isoforms (74). Thus, transcript quantifications inferred by popular tools
such as RSEM, Salmon, or kallisto carry more uncertainty, which should be accounted for in the
downstream DE analysis.
Transcript quantifications still have many of the properties of count data (e.g., mean-variance
relationships) and thus could be used as inputs to the frameworks mentioned above. However,
quantifications are estimates that may obscure inference when plugging them into count-based
RNA-seq tools. Cufflinks was one of the first methods to use estimated abundances and their
corresponding standard errors to perform DTE (and DGE) analyses; the method quantifies tran-
script abundances via a likelihood model and an EM algorithm, and tests of DE are performed by
applying the delta method on the abundance parameters (75, 86). Bayesian approaches for identi-
fying DTE based on estimated counts, e.g., ranking via Bayes factors, include EBSeq (132), which
uses an empirical Bayesian hierarchical model, and MMSeq (79, 168), which fits a linear mixed
model to data via Markov chain Monte Carlo techniques. Similarly, BitSeq (and later cjBitSeq)
introduced a generative model that couples both quantification and DE using fully Bayesian in-
ference (95, 169). Most recently, with the advent of ultrafast transcript quantification algorithms,
sleuth uses bootstrap samples of each sample of reads to determine the so-called inferential vari-
ance and integrates this into the DE calculation through a variance components model on the
log-transformed scale (170).
Differential Transcript Usage (Differential Splicing)
One of the first statistical models for DTU, cuffdiff, calculates the square root of the Jensen–
Shannon divergence on estimated transcript proportions and uses the delta method to estimate
the variance of this metric under the null hypothesis of no change in proportions (86). Another
conceptually distinct approach formulates a Poisson mixed effects model on exon- and junction-
level quantifications and searches for exon–condition interactions that represent differential usage
(171). Such departure-from-parallelism modeling was introduced in earlier analyses of probe-
level microarray data for DTU (172); on RNA-seq data, this approach was further formalized
with DEXSeq (173), which uses an NB model on exon-level counts. Exon by exon, DEXSeq tests
whether an improvement in fit is achieved by adding a single exon–condition interaction, which
represents the differential usage of that exon across conditions. A comparison study showed that
DEXSeq has a good performance in well-annotated transcriptomes and that filtering of lowly
expressed transcripts improves error control (174); in addition, DEXSeq also works well with
transcript quantifications as input (175).
In a similar vein, DRIMSeq (176) and LeafCutter (177) employ the Dirichlet-multinomial
(DM) distribution to perform the same inference task but treat the output of a gene’s expression
as a multivariate response; Bayesian inference for the DM model has also been considered in
BayesDRIMSeq (178). Several tools neglect the uncertainty in estimated transcript-level counts,
and this is perhaps the reason for inflated FDRs (175). To address this, RATs (relative abundance
of transcripts) uses bootstrapped (transcript-level) quantifications to infer DTU via a G-test of
independence, based on the multinomial distribution, on the two groups’ isoform counts (179).
Instead of considering estimated counts and their uncertainties, Bayesianmethods such as cjBitSeq
(169) focus on the group of transcripts that each read is compatible with (i.e., equivalence classes).
In this way, quantification is not required because the DS tools treat the transcript allocation of
reads as an unknown latent variable.
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Event-Level Analyses Based on Percent Spliced-In
Somemethods perform differential analyses based on percent spliced-in values (PSIs). PSIs can be
computed either for specific events (retained intron, cassette exon, etc.) or at the transcript level
and indicate the fraction of RNA-seq reads supporting the event, obtained as the ratio between
the number of reads including the event and the total number of reads including and excluding
the event. The difference of the PSIs between conditions is then used to assess DS, performed
separately for each event (or transcript). Some of the main DS tools based on PSIs include rMATS
(180), which uses an LRT, and SUPPA2 (181), whose test is based on comparing the observed
difference in PSIs across conditions to the empirical cumulative density function of the within-
replicates differences of PSIs of SJs from similarly expressed transcripts.
Event-level analysis, similar toDEXSeq’s exon-level approach, separately focuses on each splic-
ing event, and results could be aggregated to the gene level by considering the most significant
event- or transcript-level test, appropriately adjusted for multiple testing (173, 181, 182).
Multistage Testing
As mentioned, DS analyses can be approached at the gene-, transcript- or event-specific level.
While gene-level tests often have higher sensitivity, testing each individual transcript provides in-
creased resolution. However, neither gene- nor transcript-level tests guarantee FDR control on
the full set. Stagewise testing procedures (165, 166) instead first screen for significant genes and
only consider significant transcripts from those genes. This procedure gives gene-level FDR con-
trol and allows researchers to leverage the power from gene-level tests while interpreting results
at the transcript level (175). The same procedure can be applied by replacing transcript-level tests
with exon- or event-specific tests.
SINGLE-CELL TRANSCRIPTOME SEQUENCING
One of the emerging data types in transcriptomics is scRNA-seq, whereby the expressed content
of individual cells is prepared and sequenced. In this case, experimental design is again of critical
importance to avoid confounding the data (183). Experimentally, capture and reverse transcription
efficiency become important, given that the number of mRNA transcripts per mammalian cell is
estimated to be between 50 and 300 thousand (184).
Twomain experimental approaches are used: plate-based, where cells are sorted into individual
wells for lysis and library preparation, and droplet-based, where each cell is absorbed (together
with reagents) and processed within an oil droplet (185). Several variations of these protocols are
now available, increasing the number of cells assayed, but ultimately only a small fraction of the
expressed RNAs (cDNAs), often the most highly expressed transcripts, are captured. The features
that distinguish scRNA-seq from bulk RNA-seq data include (a) generally low depth of sampling
for each cell (due to cost, but also due to lower diversity of cDNA fragments); (b) so-called dropout,
where a cell expresses a transcript but it is unobserved; and (c) higher levels of biological (since no
averaging) and technical (e.g., more amplification) variation.
Nonetheless, researchers can distinguish cell identities,where identity represents the combined
effects of cell type (permanent features) and cell state (transient features) (186). The Human Cell
Atlas, among other projects, opens the door for exploring spatial context (187), developmental
patterns (188), immune responses (189), response to therapy (190), and an increasing range of
basic science and clinical investigations (191–193).
Although many computational aspects of scRNA-seq data are beyond the scope of this review
(e.g., dimensionality reduction techniques, ordering cells into lineages), one connected application
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area that has already received considerable attention is DE analysis. In the simplest setting, cells
are first partitioned into different classes (e.g., assumed to correspond to different cell types) via
clustering, with the subsequent aim of finding markers for each cluster (e.g., to annotate cell
types). To perform this task, a statistical model uses cells as experimental units, as opposed to
samples in bulk analyses; thus, it is worth considering the population to which the conclusions
extrapolate.
To date, several methods have been developed to decipher DE between cell types, many of
which have been comparatively assessed in recent benchmarks (194, 195). Many of these single
cell–specific methods are extensions or variations of existing bulk approaches. For example, SCDE
formulated the RPM (reads per million) data for a given gene across cells as a mixture of Poisson
and NB components; using a Bayesian approach, probabilities of observing a given fold change
are converted into empirical p-values (196). MAST uses a hurdle model on log(TPM + 1) data,
where a logistic regression is used to model whether a gene is expressed, and a Gaussian linear
model is used conditional on expression. Inferences for the two sets of regression parameters are
done in a Bayesian framework that also provides regularization (197). Again, extending existing
approaches, Van den Berge et al. (198) proposed a zero-inflated NB (ZINB) model; model fitting
is done within the ZINB-WaVE (wanted variation extraction) framework (199), estimating cell-
and gene-specific posterior probabilities for counts to belong to the NB count component of the
ZINB mixture model. These probabilities are used as observation weights in the downstream
estimation of regression parameters in the classical NB framework.
Nonetheless, many DEmethods focus on assessing changes in the mean parameters.However,
since cell subsets are being compared, we may not have simple shifts in the mean. Instead, it may
be informative to detect and understand changes in expression variability across conditions (200).
Alternatively, full distributions (instead ofmeans or variances) can be compared, as was proposed in
a Bayesian framework in scDD (201), highlighting not only DE but also differential proportions
(change in the relative usage of low and high expression), differential modality (change in the
number and place of the mode of expression), or some combination thereof.
Inmany applications of single-cell DE analysis, the sample sizes (numbers of cells) are generally
larger than those commonly used within the optimized frameworks built for bulk RNA-seq data,
and thus it seems that the distributional assumptions play less of a role for effective inference.
Indeed, a recent comparison highlighted decent performance of t-tests and Wilcoxon rank sum
nonparametric tests in comparing single-cell subsets (194).
Beyond comparing cell types, which may involve multiple experimental units (e.g., patients),
it will be of increasing interest to compare expression levels of genes across biological replicates
and conditions. For example, it may be of interest to understand cell-type-specific immune re-
sponses following a stimulus. A recent study compared multiple patients across stimulated and
unstimulated conditions by first computationally separating immune cell types (189); to do this,
the researchers aggregated cells from a given cell type into a pseudobulk RNA-seq data set and
performed DE using standard tools.
LONG-READ TRANSCRIPTOME SEQUENCING
The short read length of Illumina-based RNA-seq complicates the unambiguous placement of
reads to the genome, especially in repeat regions (202), and adds difficulties to the assembly,
identification, and quantification of expressed isoforms (203–205). In contrast, so-called third-
generation, or long-read, sequencing technologies, led by PacBio (206) and ONT, can generate
much longer reads.By sequencing singlemolecules, they can also forego PCR amplification, hence
reducing coverage biases (207, 208). Currently, long-read technologies incur a higher average cost
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and a higher error rate than short-read sequencing (203, 209). However, this is a rapidly develop-
ing field, and improvements in error rates and throughput are to be expected.
The strategies employed by PacBio and ONT to generate long sequencing reads of single
molecules differ in many ways. PacBio, with its RSII and Sequel instruments, uses SMRT (sin-
gle molecule real time) sequencing (210), where the reactions take place inside so-called zero-
mode waveguides (ZMWs) (211). At the bottom of each ZMW, there is a single DNA polymerase
molecule. As the polymerase processes a DNA fragment, the incorporation of each nucleotide
leads to a fluorescent signal, which is detected by the ZMW and converted to a base call. A spe-
cific characteristic of the PacBio library preparation system is the creation of SMRTbell templates
(212), which are obtained by ligating SMRTbell hairpin adapters. The result is a circular con-
struct, where the two strands of the template are separated by adapters with known sequences. As
the construct is processed by the polymerase in the ZMW, the original template can be passed
multiple times. Since the sequencing errors are largely random (213), the base-level error rate can
be considerably reduced by forming a consensus over these passes.
ONT, in contrast, uses a different sequencing strategy based on protein nanopores placed in
a polymer membrane (214) for its MinION and PromethION sequencers. A current is passed
through the nanopores, and as the template molecule is passed through the pore by a motor pro-
tein, each combination of bases induces a change in the current. Analyzing the exact nature of this
change allows for the identification of the template sequence. By adding a hairpin sequence to the
end of the double-stranded cDNA fragment before denaturing it into a single-stranded molecule
and passing it through the nanopore, both the template sequence and its complement are in-
cluded in a single read and can be combined at the base calling step to generate a higher-quality,
so-called 2D, read (215). In contrast to PacBio, ONT also offers direct sequencing of RNA (216).
Advantages of this include that the reverse transcription step is avoided, which may reduce biases,
and that RNA modifications can be directly observed, since they also change the current passing
through the nanopore in characteristic ways (217). However, at present, the required amount of
starting material is considerably higher than for cDNA protocols.
Applications to cDNA (RNA) include both transcriptome-wide sequencing and characteriza-
tion of specific genes via targeted sequencing (14, 203, 218–222), as well as performance evalua-
tions based on synthetic transcript catalogs [ERCC (External RNA Controls Consortium) with
92 sequences or SIRV (spike-in RNA variant) with 68). With LRTS, every read potentially rep-
resents a full-length transcript. If this were indeed true, de novo (reference-free) identification
of the full set of observed isoforms would be straightforward and would only require grouping
reads expected to differ only by sequencing errors (which, depending on the error rate and iso-
form similarity, may not be trivial). However, this is not currently the case, due to fragmentation
and degradation of template molecules during library preparation and early termination of the
sequencing, which leads to ambiguities in transcript identification (223). This means that it is not
easy to determine whether truncated variants are present.
Transcript identification from LRTS can be either reference-based or reference-free. The lat-
ter typically involves clustering reads based on similarity, followed by polishing the consensus
sequence within each cluster (14, 224–227). Since LRTS is still a young field, methods and tools
for reference-based alignment are still emerging but so far include a mix of established tools, such
as GMAP (58), and new innovations, such as minimap2 (228). A recent study comparing PacBio,
ONT, and Illumina data (203) showed that the long-read technologies were indeed much better
at correctly identifying expressed SIRV transcripts than de novo assemblies of short reads.
The rapid technological developments in LRTS also mean that the read generation process
(e.g., biases affecting the observation of a given read) is still largely unknown. In addition, read
lengths are extremely variable, error rates are relatively high, and throughput is still relatively low.
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For the PacBio RSII instrument, the selection of transcript molecules is biased toward short se-
quences (223). Thus, samples are typically size-fractionated before sequencing, which distorts the
abundance estimates. Taken together, these and other aspects make accurate transcript quantifica-
tion from LRTS more difficult, and new models and tools will be needed. Encouragingly, a recent
study showed that by combining LRTS and Illumina data, more accurate quantifications for the
artificial SIRV transcripts could be achieved (203).
Since abundance estimation for long reads returns values in the form of read (or transcript)
counts, it is plausible that the DE machinery developed for short-read data can be applied in a
similar way. The quality of the DE calls will be directly dependent on the accuracy of the abun-
dance estimates. However, the current low depth of sequencing compared to short-read data sets
will ultimately lead to low power to detect DE features.
SUMMARY
I’m a scientist and I know what constitutes proof. But the reason I call myself by my childhood name
is to remind myself that a scientist must also be absolutely like a child. If [they] see a thing, [they] must
say that [they] see it, whether it was what [they] thought [they] were going to see or not. See first,
think later, then test. But always see first. Otherwise you will only see what you were expecting. Most
scientists forget that.
–adapted from The Ultimate Hitchhiker’s Guide to the Galaxy by Douglas Adams
In this review, we gave an overview of the data science of gene expression analysis, with a focus
on methods to estimate transcript-level abundance and statistical tools for assessing DE.Notably,
RNA-seq data are often an intermediate discovery step where the detected molecular changes
represent candidates for further follow-up. Nonetheless, the analysis of RNA-seq data for gene
expression is already very mature, due to a deep understanding of the biases present, to the im-
plementation of efficient data structures and algorithms for processing the data into (estimated)
count tables, and to a refined understanding of how well tools perform via the many benchmarks
available.
Ultimately, the success of RNA-seq lies in its wide range of applications, and it is likely that
Illumina-based short-fragment RNA-seq will continue to be the workhorse for the field for many
years. With the increasing fidelity of single-cell protocols, many tools are emerging to deal with
the additional complexities of single-cell measurements, and these will be further refined in the
coming years. Similarly, with the decreasing costs and lower error rates of long-read technologies,
it may be possible to characterize alternative transcription quantitatively with full-length tran-
script sequencing, thus considerably reducing read-to-transcript ambiguity; however, much still
needs to be learned about the biases present.
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